Biotechnology News

SAN DIEGO and NERVIANO, Italy, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ: CRDF) ("Cardiff") and Nerviano Medical Sciences S.r.l. ("NMS") today announced that they have...

GATC to contribute AI-native, in silico drug discovery and predictive modeling expertise and insights to collaborative effort advancing the validation, qualification and adoption of human-relevant...

A new, smaller 30-count bottle of the once-daily chewable methylphenidate offers pharmacists easier stocking and patients a 30-day supply at common dosing levels, available now as families navigate...

First subjects dosed in Santa Ana Bio's Phase 1 study of SAB01, a first-in-class bispecific antibody targeting KIT and Siglec-6 for mast cell depletion.

Autoimmune diseases are characterized by high unmet medical need with most current treatments only addressing symptoms. Evaxion will apply AI-Immunology™ to target underlying pathologiesThe unique...

Alignment Reached on Key Elements of the Phase 3 Program to Support a 505(b)(2) NDA Submission 10XB-101 Now has Clear Regulatory Path Forward LA JOLLA, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) --...

Kraig Labs (OTCQB: KBLB) highlights the growing opportunity for advanced biomaterials in fashion as New York Fashion Week begins.

Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma Topline overall survival data expected as...

Invention is based on the discovery that ALS may be caused by reactivation of Human Endogenous Retrovirus K (HERV K) Envelope protein (K Env), already coded in the “dark genome” of all people. K Env...

HIGHLIGHTS Texas-based company established as dedicated U.S. vehicle for regulated ibogaine developmentPositioned to hold U.S. rights to PsyLabs’ pharmaceutical-grade ibogaine, subject to completion...